Impact of Bebtelovimab Treatment Timing on COVID-19 Outcomes in Ambulatory Solid Organ Transplant Recipients.

bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/39549258

Daniel C Brennan; Ishaan Gupta; Julie Langlee; Kristin Freed; Lauren Boyer; Mary Grace Bowring; Robin K Avery; Sonsoles Salto-Alejandre; Sophia Purekal; Willa Cochran; William Werbel; Zishan Siddiqui

Nov 18, 2024